Exam 3 Flashcards
(170 cards)
Renal Elimination: Older age risks (5)
- Organs systems decline (atrophy of kidney)
- Decreased # of functional nephrons -> decreased GFR
- More prone to development of AKI, CKD, and ESKD
- higher risk for HTN and DM which cause ESKD
- Risk for dehydration r/t sodium retention, increased dilution of urine, and decreased thirst perception
Renal Elimination: Risky Medications (5)
- Antibiotics (aminoglycosides)
- Iodine Contrast-dye
- Immunosuppressives (steroids, transplant meds)
- NSAIDs
- ARBs and ACEIs
Most common causes of AKI (4)
- Sepsis or overwhelming infection - leading cause of death
- Hypovolemia
- Drug or medication-related
- Cardiogenic shock
AKI: Basics (5)
- Abrupt reduction in renal function over a period of hours or days
- Decrease in GFR
- increased BUN, Creatinine, and K+
- with/without oliguria (urine output < 30cc/hr or <400 cc/day).
- Retention of waste products (azotemia)
Multisystem effects of ESKD
- neurologic
- hematologic
- skeletal
- cardiovascular
- GI
- GU
- Dermatologic
- Respiratory
- Neurologic (coma, headache, inattentiveness, lethargy, seizures)
- Hematologic (bleeding, immunosuppression, platelet dysfunction)
- Skeletal (hyperphosphatemia, hypocalcemia, weak, brittle bones)
- Cardiovascular (arrhythmias, Edema, heart failure, HTN, pericarditis, pericardial)
- GI (anorexia, decreased appetite, hypomotility, glucose intolerance, hyperphosphatemia)
- GU (amenorrhea, hematuria, proteinuria)
- Dermatologic (dry skin, poor healing, pruritus)
- Respiratory (Pleural effusions)
RIFLE Criteria
Risk
- Crt 1.5x normal OR Crt increases ≥ 0.3 mg/dL
Injury
- Crt 2x normal
Failure
- Crt 3x normal OR ≥ 4 mg/dL
Loss
- Persistent AKI = complete loss of kidney function for more than 4 wks.
ESKD
- End-stage kidney disease
AKI: Onset Phase (3)
- Begins when the kidney is injured causing ischemia and decreased GFR
- Ends when oliguria develops (goal to detect prior to this)
- Duration: lasts from hours to days.
AKI: Oliguric/Anuric Phase
Duration
S/s (2)
Labs (4)
Duration: a range of 8-14 days depending on nonoliguric vs. oliguric.
s/s
- Urine production is < 400 cc for 24 hrs
- Fluid overload (b-c inability to excrete water)
Labs
- Greatly reduced GFR and urine formation due to renal tubule damage
- increased BUN, Creatinine,
- Electrolyte disturbances (Hyperkalemia, hyperphosphatemia, hypocalcemia)
- Metabolic acidosis
AKI: Diuretic Phase
Duration
5 notes
Duration: Lasts 7- 14 days
- Occurs when cause of AKI corrected
- GFR increases but nephrons still not fully functional
- Unable to excrete some waste products
- tubule scarring and damage and edema present
- Urine > 400 cc in 24 hours (up to 2-5L/24 hr) -> high BUN (observe for dehydration)
AKI: Recovery Phase
Duration
3 notes
Duration: lasts several months to 1 yr.
- Normalization of F/E balance or onset of polyuria
- Return of GFR to 70-80% normal (Normal GFR: 120)
- Tubular edema resolves and renal function improves
Pre-renal AKI: Causes (4)
- Prolonged hypotension (sepsis, vasodilation)
- Prolonged low CO (CHF, cardiogenic shock)
- Prolonged volume depletion (Hemorrhage, Diarrhea, dehydration, burns)
- Renovascular thrombosis
Intrarenal/Intrinsic AKI: Causes (6)
- Acute tubular necrosis [ischemic (trauma, sepsis); advanced prerenal AKI]
- Meds (NSAIDS, aminoglycosides (gentamicin), cephalosporins, amphotericin B, acyclovir)
- Glomerular diseases [glomerulonephritis (acute), lupus, nephritis)
- Nephrotoxic agents (environmental, contrast dye, cocaine)
- Rhabdomyolysis
- Tumor lysis syndrome
Postrenal AKI: Causes (4)
- BPH
- Kidney stones (calculi)
- Urethral strictures
- Tumors
Categories of AKI (what is it and priority care)
- Prerenal (2)
- Intrarenal (2)
- Postrenal (2)
Prerenal
- Decreased perfusion (renal blood flow, BP, Low cardiac output, MAP < 65) cause kidney ischemia
- Priority: establish hemodynamic stability
Intrarenal
- direct damage to kidneys
- Priority: maintain renal perfusion, discontinue nephrotoxic drugs, treat cause
Postrenal
- obstruction of urine flow from kidneys
- Priority: prevent UTI, remove source of obstruction, ensure catheter patency, maintain renal perfusion
Sepsis and AKI
Patho (2)
Labs
Care (3)
Patho
- Sepsis causes reduced perfusion to kidney -> hemodynamic instability and ischemia
- Inflammation increases vascular permeability and causes third spacing
Labs: elevated WBC and lactate plus AKI labs
Care
- Need rapid fluid resuscitation then vasopressors in septic shock
- Avoid aminoglycosides
- Prevention: MAP > 65
Trauma and AKI: Rhabdomyolysis
What is it?
Risks (3)
S/s (3)
Primary treatment (3)
What is it?
- release of myoglobin and creatine from damaged muscle cells after burns, trauma, crush injuries
Risks
- life-threatening hyperkalemia due to cell lysis
- metabolic acidosis
- AKI from myoglobin toxicity (myoglobinuria and hemoglobinuria)
S/s
- compartment syndrome
- elevated CK, crt, K
- dark brown or tea colored urine (myoglobinuria and hematuria)
Primary treatment
- IV crystalloid fluid resuscitation (NS, LR)
- sodium bicarb for acidosis and to alkalize urine for myoglobin excretion
- Mannitol to increase renal blood flow and GFR for myoglobin clearance
At-risk disease states and AKI
- Heart failure (2)
- Respiratory failure (2)
Heart failure and AKI
- Several risk factors overlap
- BP: 130/80 and normal range glucose recommended to prevent CKD and atherosclerotic changes (CAD, PAD)
Respiratory failure and AKI
- Mechanical ventilation (PEEP and positive-pressure) alter kidney via reduced renal blood flow, GFR, UOP
- AKI increases inflammation and risk for ARDS which can lead to ventilation dependence
Contrast-induced nephrotoxic (CIN) injury and AKI
Risk factors (4)
Prevention (5)
Risk factors: CKD, Crt > 1.5, dehydrated pts, CHF, advanced age (> 75)
Prevention
- Stop metformin day before and resume 48 hrs procedure w/ contrast dye (risk for lactic acidosis)
- Promote hydration and avoid dehydration (IV fluids) before, during, and after
- use lowest dose of dye
- do not repeat dye doses within 48 hrs
- Remove nephrotoxic drugs (NSAIDs, diuretics, ACEI, ARBs)
AKI: Labs (7)
- metabolic acidosis (increased anion gap, low bicarb, low pH)
- elevated BUN (not reliable indicator of AKI)
- elevated Crt (late indicator)
- Decreased Creatinine Clearance /GFR (<50) ->most accurate indicator of kidney function
- BUN: Crt ratio (normal = intrarenal AKI; high = prerenal AKI from high BUN)
- Electrolytes (hyperkalemia, hypocalcemia, hyperphosphatemia; hypo/hypernatremia)
- Anemia (decreased H/H due to kidneys not producing erythropoietin)
AKI: Physical Assessment (7)
- Chest pain or pressure
- Fluid overload or loss (oliguria to diuretic)
- Intravascular overload (CHF, pulmonary congestion, high BP)
- Edema r/t fluid retention, low albumin, inflammation
- Grey-turner sign (kidney trauma seen on flank)
- Bruit = aneurysm or stenosis
- Azotemia = uremia
Prerenal AKI: Urine Changes (4)
- Increased urine osmolality (decreased serum osmolality)
- Increased urine specific gravity
- Decreased urine sodium
- Urine sediment is absent
Intrarenal AKI: Urine changes (6)
- Increased acidity of urine (retention of sodium and acids by body causes retention of bicarb)
- RBC in urine (hematuria, smoky, red)
- BUN in urine
- Decreased urine osmolality (increased serum osmolality)
- increased or normal urine sodium
- Sediment (casts and epithelial cells), protein, glucose in urine b-c damaged tubules (glucosuria unreliable marker for DM in AKI)
AKI and Electrolyte Balance: Treatments
- Hyperkalemia (2)
- Hypocalcemia
- Hyperphosphatemia (3)
Hyperkalemia (>5)
- IV diuretics if making urine (dialysis if oliguria)
- DICK (Dextrose, Insulin, Calcium gluconate, kayexalate)
Hypocalcemia (< 8.5)
- calcium and vitamin D supplements b-c risk for renal osteodystrophy
Hyperphosphatemia (> 4.5)
- give phosphorus binders w/ every meal
- frequent skin care for pruritus
- Limit phosphorus food (high protein aka meat, fish, dairy, additives, carbonated beverages)
AKI: Fluid balance care (5)
- fluid resuscitation (2-3L/day)
- fluid restriction if UOP < 400 cc/24 hr)
- daily weights and I & O ( 1L = 1 Kg; output 30 mL/hr)
- remove foley once pt stable to prevent CAUTI
- monitor for s/s of bleeding or anemia